Table 2 Univariable and multivariable Cox regression, factors impacting on molecular event-free survival.
From: FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML
Characteristic | Univariable | Multivariable | ||||
|---|---|---|---|---|---|---|
HR | 95% CI | p value | HR | 95% CI | p value | |
Age | 1.03 | 1.00–1.06 | 0.02 | 1.03 | 1.00–1.06 | 0.06 |
MRD markera | 0.45 | 0.14–1.52 | 0.20 | |||
FLT3-ITD at diagnosis | 0.93 | 0.22–3.94 | 0.92 | |||
Previous midostaurin | 1.47 | 0.65–3.35 | 0.35 | |||
On midostaurin at time of molecular failure | 2.39 | 1.05–5.46 | 0.04 | 2.23 | 0.74–6.74 | 0.20 |
Previous allo-SCT | 0.36 | 0.14–0.97 | 0.04 | 0.85 | 0.27–2.63 | 0.80 |
Molecular failure typeb | 2.15 | 0.93–4.94 | 0.07 | 1.28 | 0.51–3.22 | 0.60 |
Time between diagnosis and molecular failure | 0.93 | 0.86–1.00 | 0.05 | 0.98 | 0.89–1.07 | 0.60 |
qPCR copy number at molecular failure (per 100 increase) | 1.74 | 1.14–2.64 | 0.01 | 1.84 | 1.10–3.07 | 0.02 |